PriceTargets.com logo

Assura - AGR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: GBX 52
  • Forecasted Upside: 26.83%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
GBX 41 As of 04/19/2024 01:00 AM ET
▲ +0.34 (0.84%)

This chart shows the closing price for AGR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Assura Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AGR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGR

Analyst Price Target is GBX 52
▲ +26.83% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Assura in the last 3 months. The average price target is GBX 52, with a high forecast of GBX 56 and a low forecast of GBX 48. The average price target represents a 26.83% upside from the last price of GBX 41.

This chart shows the closing price for AGR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 investment analysts is to moderate buy stock in Assura. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/20/2024Peel HuntDowngradeAddGBX 48
2/9/2024BarclaysReiterated RatingOverweightGBX 53
11/20/2023Berenberg BankBoost TargetBuyGBX 49 ➝ GBX 51
11/17/2023BarclaysBoost TargetOverweightGBX 52 ➝ GBX 53
11/16/2023Shore CapitalInitiated CoverageBuy
7/6/2023Shore CapitalReiterated RatingBuy
5/24/2023JPMorgan Chase & Co.Reiterated RatingNeutralGBX 56
5/24/2023BarclaysReiterated RatingOverweightGBX 57
5/23/2023Peel HuntReiterated RatingBuyGBX 65
5/23/2023Shore CapitalReiterated RatingBuy
1/18/2023JPMorgan Chase & Co.Lower TargetNeutralGBX 62 ➝ GBX 56
1/17/2023BarclaysReiterated RatingBuyGBX 60
12/1/2022BarclaysLower TargetOverweightGBX 73 ➝ GBX 60
12/1/2022Berenberg BankLower TargetHoldGBX 75 ➝ GBX 65
11/23/2022Shore CapitalReiterated RatingBuy
8/31/2022Berenberg BankLower TargetHoldGBX 80 ➝ GBX 75
7/14/2022Shore CapitalReiterated RatingBuy
7/6/2022Shore CapitalReiterated RatingBuy
7/4/2022BarclaysLower TargetOverweightGBX 80 ➝ GBX 73
5/31/2022Berenberg BankReiterated RatingHoldGBX 80
5/25/2022JPMorgan Chase & Co.Reiterated RatingOverweightGBX 79
5/24/2022Peel HuntReiterated RatingAddGBX 85
5/24/2022Shore CapitalReiterated RatingBuy
5/23/2022BarclaysReiterated RatingOverweightGBX 80
5/9/2022BarclaysReiterated RatingOverweightGBX 80
4/29/2022BarclaysReiterated RatingOverweightGBX 80
4/19/2022BarclaysReiterated RatingOverweightGBX 80
4/13/2022Berenberg BankReiterated RatingHoldGBX 80
4/5/2022BarclaysReiterated RatingOverweightGBX 80
4/1/2022Shore CapitalReiterated RatingBuy
3/21/2022BarclaysReiterated RatingOverweightGBX 80
3/16/2022Shore CapitalReiterated RatingBuy
3/8/2022BarclaysReiterated RatingOverweightGBX 87
3/1/2022Shore CapitalReiterated RatingBuy
2/14/2022BarclaysReiterated RatingOverweightGBX 87
1/31/2022BarclaysReiterated RatingOverweightGBX 87
12/8/2021Liberum CapitalLower TargetHoldGBX 77 ➝ GBX 70
12/1/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 79
11/30/2021BarclaysReiterated RatingOverweightGBX 87
11/30/2021Shore CapitalReiterated RatingCoverage Pending
11/24/2021Liberum CapitalReiterated RatingHold
11/11/2021Berenberg BankReiterated RatingOverweightGBX 87
11/11/2021Peel HuntReiterated RatingAddGBX 85
11/11/2021Peel HuntReiterated RatingAddGBX 85
11/11/2021Shore CapitalReiterated RatingCoverage Pending
11/11/2021Liberum CapitalReiterated RatingHoldGBX 77
10/13/2021BarclaysReiterated RatingOverweightGBX 87
5/19/2021Berenberg BankBoost TargetHoldGBX 75 ➝ GBX 80
5/18/2021Peel HuntReiterated RatingAddGBX 85
5/18/2021Peel HuntReiterated RatingAddGBX 85
5/18/2021Liberum CapitalReiterated RatingHoldGBX 75
5/18/2021Numis SecuritiesReiterated RatingAddGBX 88
2/17/2021Jefferies Financial GroupBoost TargetBuyGBX 87 ➝ GBX 90
7/7/2020Peel HuntReiterated RatingAdd
7/7/2020Liberum CapitalReiterated RatingHold
6/2/2020Liberum CapitalReiterated RatingHoldGBX 80
5/25/2020Berenberg BankBoost TargetHoldGBX 75 ➝ GBX 80
5/25/2020Jefferies Financial GroupLower TargetBuyGBX 94 ➝ GBX 87
5/22/2020BarclaysReiterated RatingOverweight
5/21/2020Peel HuntReiterated RatingAdd
5/21/2020Liberum CapitalReiterated RatingHold
5/6/2020Berenberg BankDowngradeHold
5/6/2020Peel HuntUpgradeAddGBX 80 ➝ GBX 85
4/15/2020BarclaysBoost TargetOverweightGBX 81 ➝ GBX 85
4/9/2020Berenberg BankDowngradeHold
4/8/2020JPMorgan Chase & Co.Boost TargetOverweightGBX 81 ➝ GBX 83
4/7/2020Liberum CapitalReiterated RatingHold
4/2/2020Jefferies Financial GroupBoost TargetBuyGBX 79 ➝ GBX 94
4/2/2020Peel HuntReiterated RatingHold
3/13/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/11/2020Berenberg BankReiterated RatingHold
2/11/2020Peel HuntReiterated RatingHold
1/27/2020Liberum CapitalBoost TargetHoldGBX 76 ➝ GBX 80
1/16/2020JPMorgan Chase & Co.Boost TargetOverweightGBX 79 ➝ GBX 81
1/13/2020Peel HuntReiterated RatingHold
1/13/2020Liberum CapitalReiterated RatingHold
1/7/2020Peel HuntReiterated RatingHold
12/17/2019Peel HuntBoost TargetHoldGBX 62 ➝ GBX 80
12/13/2019Jefferies Financial GroupReiterated RatingBuy
12/6/2019Liberum CapitalReiterated RatingHold
12/3/2019BarclaysInitiated CoverageOverweightGBX 81
12/3/2019Peel HuntReiterated RatingHold
11/29/2019Berenberg BankInitiated CoverageHoldGBX 75
11/26/2019Peel HuntReiterated RatingHold
11/12/2019Peel HuntReiterated RatingHoldGBX 62
11/12/2019Peel HuntReiterated RatingHoldGBX 62
11/12/2019Liberum CapitalReiterated RatingHoldGBX 76
11/5/2019Peel HuntReiterated RatingHold
10/22/2019Peel HuntReiterated RatingHold
10/15/2019Peel HuntReiterated RatingHold
10/7/2019Peel HuntReiterated RatingHold
10/1/2019Peel HuntReiterated RatingHold
9/17/2019Peel HuntReiterated RatingHold
9/10/2019Peel HuntReiterated RatingHold
8/27/2019Peel HuntReiterated RatingHold
8/9/2019Peel HuntReiterated RatingHold
7/9/2019Peel HuntReiterated RatingHold
7/2/2019Liberum CapitalReiterated RatingHold
7/2/2019Peel HuntReiterated RatingHold
6/25/2019Peel HuntReiterated RatingHold
6/17/2019Peel HuntBoost TargetHoldGBX 56 ➝ GBX 62
6/11/2019Peel HuntReiterated RatingHold
6/4/2019Peel HuntReiterated RatingHold
5/28/2019Peel HuntReiterated RatingHold
5/21/2019Peel HuntReiterated RatingHold
5/21/2019Liberum CapitalReiterated RatingHold
5/14/2019Peel HuntReiterated RatingHold
5/8/2019Peel HuntReiterated RatingHold
(Data available from 4/20/2019 forward)

News Sentiment Rating

0.90 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Assura logo
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Read More

Today's Range

Now: GBX 41
Low: 40.31
High: 41.02

50 Day Range

MA: GBX 41.72
Low: 40.06
High: 43.20

52 Week Range

Now: GBX 41
Low: 38.38
High: 53

Volume

3,863,743 shs

Average Volume

8,097,452 shs

Market Capitalization

£1.22 billion

P/E Ratio

N/A

Dividend Yield

7.83%

Beta

0.3

Frequently Asked Questions

What sell-side analysts currently cover shares of Assura?

The following Wall Street sell-side analysts have issued stock ratings on Assura in the last twelve months: Barclays PLC, Berenberg Bank, JPMorgan Chase & Co., Peel Hunt, and Shore Capital.
View the latest analyst ratings for AGR.

What is the current price target for Assura?

4 Wall Street analysts have set twelve-month price targets for Assura in the last year. Their average twelve-month price target is GBX 52, suggesting a possible upside of 26.8%. JPMorgan Chase & Co. has the highest price target set, predicting AGR will reach GBX 56 in the next twelve months. Peel Hunt has the lowest price target set, forecasting a price of GBX 48 for Assura in the next year.
View the latest price targets for AGR.

What is the current consensus analyst rating for Assura?

Assura currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AGR.

What other companies compete with Assura?

Other companies that are similar to Assura include Primary Health Properties, Target Healthcare REIT, Impact Healthcare REIT, Countryside Partnerships and St. Modwen Properties. Learn More about companies similar to Assura.

How do I contact Assura's investor relations team?

Assura's physical mailing address is The Brew House, Greenalls Avenue, WARRINGTON, WA4 6HL, United Kingdom. The real estate investment trust's listed phone number is +44-1925-420660. The official website for Assura is www.assuraplc.com. Learn More about contacing Assura investor relations.